Mammalian rad1 genes, polypeptides and methods of use
CA 2268457 A1 · Owner: Queen'S University At Kingston · Inventors: Davey, Scott K.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides isolated nucleic acid molecules encoding mammalian RAD1p polypeptides (such as human and marine RAD1p polypeptides) and allelic variants, mutants fragments or derivatives thereof. , The invention also provides mammalian RAD1p polypeptides encoded by such isolated nucleic acid molecules, antibodies binding to such polypeptides genetic, constructs comprising such nucleic acid molecules prokaryotic or eukaryotic , host, cells comprising such genetic constructs and methods and compositions for use, in diagnosing and treating disorders characterized by or utilizing, a loss of , cell, cycle checkpoint control or by increased sensitivity to DNA-damaging agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 19, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 19, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 19, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.